Australian Hospitality Stock News

EQ Resources (ASX:EQR) has completed a A$34 million follow on equity offering at A$0.05 per share, adding 680,000,000 new ordinary shares. This move directly affects valuation and ownership dilution. See our latest analysis for EQ Resources. The follow on equity offering comes after a period of very strong momentum, with a 30 day share price return of 31.25% and a 90 day share price return of 288.89%. The 1 year total shareholder return is also very large, suggesting sentiment has been...

Potential Great Western Exploration Limited ( ASX:GTE ) shareholders may wish to note that the Non-Executive Director...

Anyone interested in Chrysos Corporation Limited ( ASX:C79 ) should probably be aware that the Founder & Non-Executive...

Syrah Resources (ASX:SYR) has put out a busy update, pairing its full year 2025 earnings, which show sales of US$33.38 million and a net loss of US$100.66 million, with a A$104 million rights offering. See our latest analysis for Syrah Resources. The A$0.125 share price reflects a sharp reset in expectations, with a 30 day share price return of 47.92% and a 1 year total shareholder return of 47.41% loss, underscoring fading momentum despite the earnings update and capital raise. If this kind...

Why Lynas Rare Earths is on investors’ radar Lynas Rare Earths (ASX:LYC) has drawn attention after a strong period for its share price, with total return over the past year and past 3 months well ahead of its shorter term moves. For investors, the recent performance raises questions about how the current A$20.08 share price lines up with Lynas Rare Earths’ A$715.89 million in revenue, A$82.35 million in net income and its A$20.21b market value. See our latest analysis for Lynas Rare...

In March 2026, 4DMedical Limited completed a follow-on equity offering of A$83.00 million, issuing 14,067,797 new ordinary shares at A$5.90 each, reflecting a A$0.236 per-share discount in a subsequent direct listing. This sizeable capital raise signals management’s commitment to bolstering the balance sheet and funding growth initiatives, while also diluting existing shareholders’ ownership stakes. We’ll now explore how this A$83.00 million equity raise may reshape 4DMedical’s investment...

Why Brightstar Resources (ASX:BTR) Is Back On Investors’ Radar Brightstar Resources (ASX:BTR) has drawn fresh attention after analysts cut earnings and revenue forecasts for 2026, now expecting a loss, even as projections still point to strong revenue growth versus sector peers. See our latest analysis for Brightstar Resources. Brightstar’s 7 day share price return of 4.41% comes after a recent A$175m follow on equity offering and analyst forecast downgrades. However, the 30 day share price...

Life360 share performance sets context for recent moves Life360 (ASX:360) has drawn fresh attention after recent share price volatility, with the stock showing a 1.6% gain on the day and a 6.7% rise over the past week, despite weaker returns over the past month and past three months. See our latest analysis for Life360. The recent 6.7% 7-day share price return comes after a much weaker stretch. The 30-day share price return of 16.4% and year-to-date share price return of 40.6% indicate fading...

In March 2026, Telix Pharmaceuticals resubmitted its New Drug Application to the FDA for TLX101-Px (Pixclara, 18F-FET), an investigational PET imaging agent for distinguishing recurrent or progressive glioma from treatment effects in adult and pediatric patients, incorporating additional data and analysis requested after a prior Complete Response Letter. The filing is significant because TLX101-Px holds both Orphan Drug and Fast Track designations and could become the first FDA-approved...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Today is shaping up negative for Magellan Financial Group Limited ( ASX:MFG ) shareholders, with the analysts...

Insiders who bought LARK Distilling Co. Ltd. ( ASX:LRK ) stock in the last 12 months were richly rewarded last week...

In recent days, Xero and Anthropic announced a multi-year partnership to embed Claude’s AI into Xero’s platform and bring Xero financial data into Claude.ai, alongside the earlier launch of online bill payments in the US following Xero’s acquisition of Melio. Together, these moves deepen Xero’s AI automation and embedded payments capabilities, aiming to make day‑to‑day financial workflows faster and more integrated for small businesses and their advisors. Next, we’ll explore how Xero’s...

Syrah Resources (ASX:SYR) has opened FY 2025 with first half revenue of US$2.0 million and a basic EPS loss of US$0.0598, alongside a net income loss of US$59.8 million that keeps the business firmly in the red. Over recent periods the company has seen revenue move from US$19.0 million in 1H 2024 to US$12.5 million in 2H 2024 and US$14.5 million on a trailing twelve month basis to 1H 2025. Trailing EPS sits at a loss of US$0.1189 and net income at a loss of US$118.0 million, creating a...

AMP (ASX:AMP) has approved a new share buyback program, authorizing the repurchase of up to 253,984 shares for A$150 million through 31 December 2026, a move that directly affects AMP stockholders. See our latest analysis for AMP. AMP's share price has been under pressure in recent months, with a 90 day share price return of 31.32% and a year to date share price return of 31.69%. The 3 year total shareholder return of 29.94% tells a more resilient long term story. If this buyback has you...

BHP Group (ASX:BHP) is back in focus after outlining a bigger role for its Jansen potash project from 2027, increased iron ore sales into India, and a planned CEO transition to Brandon Craig in 2026. See our latest analysis for BHP Group. Recent announcements around the Jansen potash ramp up, increased iron ore shipments to India and the planned CEO transition have come against a mixed backdrop, with a 10.41% 90 day share price return and a 32.19% 1 year total shareholder return suggesting...

Earlier this month, National Australia Bank Limited completed a US$15 million fixed-income offering of 4.80% senior unsecured callable notes due March 20, 2036, issued as Eurobonds under Regulation S. Around the same time, NAB moved to restructure part of its business by cutting roughly 170 net roles while adding new offshore positions in India and Vietnam, underscoring its focus on cost efficiency and operating model reshaping. We’ll now examine how NAB’s workforce restructure, including...

Vulcan Energy Resources (ASX:VUL) has laid out its FY 2025 first half scorecard with revenue of €4.1 million and a basic EPS loss of €0.14, alongside a net loss of €30.7 million that keeps the business firmly in investment mode. The company has seen revenue move from €3.8 million in 1H 2024 to €7.6 million in 2H 2024 and then €4.1 million in 1H 2025, while basic EPS losses shifted from €0.11 in 1H 2024 to €0.12 in 2H 2024 and €0.14 in the latest half. This sets up a clear focus on how quickly...

Lynas Rare Earths recently entered into a framework agreement with South Korea’s LS Eco Energy and LS Cable & System to co-develop a rare earth metal facility in Vietnam, which will process oxides from its Malaysian and Australian operations into higher-value metals for permanent magnet production. This planned move further along the value chain could deepen Lynas’s role in non-Chinese rare earth supply, potentially influencing how investors view its integration, customer reach, and exposure...

WHSP Holdings (ASX:SOL) has opened H1 2026 reporting season with H2 2025 revenue of A$605.9 million and basic EPS of A$0.11, alongside trailing twelve month revenue of about A$3.4 billion and basic EPS of A$6.77 that frame the latest earnings run rate. Over recent halves, the company has seen revenue move from A$539.2 million and EPS of A$0.61 in H2 2024 to A$807.8 million and EPS of A$1.00 in H1 2025, before landing at A$605.9 million and EPS of A$0.11 in H2 2025. This sets up an earnings...

4DMedical (ASX:4DX) has moved back into focus after filing a follow-on equity offering of about A$83 million, pricing 14,067,797 new ordinary shares at A$5.90 each. See our latest analysis for 4DMedical. The follow on offering comes after a period of strong momentum, with 4DMedical’s 7 day share price return of 52.43% and 30 day share price return of 74.44% feeding into a very large 1 year total shareholder return. This suggests that sentiment around the company’s growth potential and risk...

West African Resources (ASX:WAF) has drawn fresh attention after reporting full year 2025 earnings, with sales of A$1,543 million and net income of A$473.9 million, along with higher basic and diluted earnings per share. See our latest analysis for West African Resources. Despite the strong full year 2025 earnings, the 30 day share price return of 14.16% and 90 day share price return of 3.5% suggest momentum has cooled recently. At the same time, the 1 year total shareholder return of 32.31%...

The Australian market is facing a challenging period, with shares poised for a drop amid geopolitical tensions and natural disruptions affecting key sectors. In such turbulent times, investors often turn to penny stocks as they seek opportunities in smaller or less-established companies that might offer growth potential. Despite the term's outdated connotations, penny stocks remain relevant for those looking to uncover value in companies with strong financials and promising prospects.